Gene · 3145
Papers3,427
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 3,427
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A case report on variegate porphyria after etonogestrel placement. | JAAD Case Rep | 2022 | 35360373 | PubTator, text mining | PubMed |
| Rostrocaudal patterning and neural crest differentiation of human pre-neural spinal cord progenitors in vitro. | Stem Cell Reports | 2022 | 35334218 | PubTator, text mining | PubMed |
| Genomic signatures of high-altitude adaptation and chromosomal polymorphism in geladas. | Nat Ecol Evol | 2022 | 35332281 | PubTator, text mining | PubMed |
| A review of the genetic spectrum of hereditary spastic paraplegias, inherited neuropathies and spinal muscular atrophies in Africans. | Orphanet J Rare Dis | 2022 | 35331287 | PubTator, text mining | PubMed |
| Evaluation of Metabolic Changes in Acute Intermittent Porphyria Patients by Targeted Metabolomics. | Int J Mol Sci | 2022 | 35328641 | PubTator, text mining | PubMed |
| Analytic and Clinical Validation of a Pan-Cancer NGS Liquid Biopsy Test for the Detection of Copy Number Amplifications, Fusions and Exon Skipping Variants. | Diagnostics (Basel) | 2022 | 35328282 | PubTator, text mining | PubMed |
| hTERT DNA Methylation Analysis Identifies a Biomarker for Retinoic Acid-Induced hTERT Repression in Breast Cancer Cell Lines. | Biomedicines | 2022 | 35327497 | PubTator, text mining | PubMed |
| Cutting-Edge Therapies and Novel Strategies for Acute Intermittent Porphyria: Step-by-Step towards the Solution. | Biomedicines | 2022 | 35327450 | PubTator, text mining | PubMed |
| Screening and Identification of Putative Long Non-Coding RNA in Childhood Obesity: Evaluation of Their Transcriptional Levels. | Biomedicines | 2022 | 35327332 | PubTator, text mining | PubMed |
| Pectoralis major muscle atrophy is associated with mitochondrial energy wasting in cachectic patients with gastrointestinal cancer. | J Cachexia Sarcopenia Muscle | 2022 | 35316572 | PubTator, text mining | PubMed |
| Cadmium acute exposure induces metabolic and transcriptomic perturbations in human mature adipocytes. | Toxicology | 2022 | 35301059 | PubTator, text mining | PubMed |
| A network-based approach to integrate nutrient microenvironment in the prediction of synthetic lethality in cancer metabolism. | PLoS Comput Biol | 2022 | 35286311 | PubTator, text mining | PubMed |
| Enhanced antigen cross-presentation in human colorectal cancer-associated fibroblasts through upregulation of the lysosomal protease cathepsin S. | J Immunother Cancer | 2022 | 35264435 | PubTator, text mining | PubMed |
| Histone deacetylase inhibitors inhibit cervical cancer growth through Parkin acetylation-mediated mitophagy. | Acta Pharm Sin B | 2022 | 35256949 | PubTator, text mining | PubMed |
| Long-term follow-up of acute porphyria in female patients: Update of clinical outcome and life expectancy. | Mol Genet Metab Rep | 2022 | 35242573 | PubTator, text mining | PubMed |
| Hereditary Coproporphyria Mimicking Guillain-Barré Syndrome After COVID-19 Infection. | Cureus | 2022 | 35228944 | PubTator, text mining | PubMed |
| Leishmaniac Quest for Developing a Novel Vaccine Platform. Is a Roadmap for Its Advances Provided by the Mad Dash to Produce Vaccines for COVID-19? | Vaccines (Basel) | 2022 | 35214706 | PubTator, text mining | PubMed |
| (De)Activation (Ir)Reversibly or Degradation: Dynamics of Post-Translational Protein Modifications in Plants. | Life (Basel) | 2022 | 35207610 | PubTator, text mining | PubMed |
| Iron in Porphyrias: Friend or Foe? | Diagnostics (Basel) | 2022 | 35204362 | PubTator, text mining | PubMed |
| Modeling oxidative injury response in human kidney organoids. | Stem Cell Res Ther | 2022 | 35189973 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3145/papers?page=28